1. Caesar, M., Stille, W. Die Chemotherapeutika der Nalidixinsäure-Gruppe. Eine Dokumentation. W. Zuckschwerdt Verlag, München 1984, pp. 34–38.
2. King, A., Shannon, K., Phillips, I. Thein vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acid. J. Antimicrob. Chemother. 13 (1984) 325–331.
3. Knothe, H., Shah, P. M., Schäfer, V., Enzensberger, R. Die antibakterielle Aktivität von Ciprofloxacin, Ofloxacin und Norfloxacin im Vergleich zu anderen Chemotherapeutika gegenüber enteropathogenen Bakterien. FAC 3–5 (1984) 615–620.
4. Rosenthal, E. J. K.: Activity of gyrase-inhibitors compared to that of lactams against gram-negative aerobic bacilli and oxacillin-resistantStaphylococcus aureus. Fourth Medical Congress of Chemotherapy, Rhodos, Greece 1984, Abstract 707.
5. Brumfitt, W., Franklin, I., Grady, D., Hamilton-Miller, J. M. T., Iliffe, A. Changes in the pharmacokinetics of ciprofloxacin and faecal flora during administration of a seven-day course to human volunteers. Antimicrob. Agents Chemother. 26 (1984) 757–761.